Reduction of digitalis glycoside intoxication by rational dosing procedures.
D000367:Age Factors; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy; D003404:Creatinine / Q000378:metabolism; D004074:Digitoxin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000506:poisoning* / Q000627:therapeutic use / Q000652:urine; D004077:Digoxin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000506:poisoning* / Q000627:therapeutic use / Q000652:urine; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D000860:Hypoxia / Q000378:metabolism; D007408:Intestinal Absorption; D007475:Ion Exchange Resins / Q000627:therapeutic use; D007677:Kidney Function Tests; D007700:Kinetics; D008657:Metabolic Clearance Rate; D008722:Methods; D008954:Models, Biological; D009206:Myocardium / Q000378:metabolism; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011863:Radioimmunoassay; D013961:Thyroid Gland / Q000503:physiopathology; D014882:Water-Electrolyte Balance
D007475:Ion Exchange Resins; D010672:Phenytoin; D004077:Digoxin; D003404:Creatinine; D004074:Digitoxin; D011342:Procainamide